Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 30 April 2014 and unaudited. Performance at month end with net income reinvested One Three One Three launch Month Months Year Years (20 Sep 04) Net asset value* (undiluted) -2.6% 4.0% 11.9% 19.4% 198.7% Net asset value* (diluted) -2.1% 3.4% 10.6% 21.9% 195.5% Share price -2.2% 1.0% 14.8% 25.9% 192.4% FTSE World Europe ex UK 0.4% 6.6% 14.8% 17.9% 140.2% Sources: BlackRock and Datastream At month end Net asset value (capital only): 248.68p Net asset value (including income): 249.57p Net asset value (capital only)*: 245.90p Net asset value (including income)*: 246.61p Share price: 243.00p Discount to NAV (including income): 2.6% Discount to NAV (including income)*: 1.5% Subscription share price: 18.00p Net cash: 2.3% Net yield**: 2.5% Total assets (including income): £268.5m Ordinary shares in issue***: 107,575,830 Subscription shares: 21,900,076 * Diluted for subscription shares and treasury shares ** Based on a final dividend of 4.5p per share for the year ended 31 August 2013 (excluding a special dividend of 1.0p) and an interim dividend of 1.5p per share for the year ending 31 August 2014. *** Excluding 5,429,676 shares held in treasury Sector Analysis Total Assets (%) Country Analysis Total Assets (%) Financials 33.4 France 22.2 Industrials 21.8 Germany 15.3 Consumer Services 11.3 Switzerland 13.1 Consumer Goods 12.9 Netherlands 9.5 Health Care 9.1 Denmark 7.3 Basic Materials 4.1 Sweden 5.9 Technology 3.1 Italy 4.8 Utilities 1.9 Belgium 4.5 Oil & Gas 1.3 Spain 3.5 Net current assets 1.1 Ireland 3.0 ----- Turkey 2.9 100.0 Portugal 2.9 ===== Russia 2.8 Hungary 1.2 Net current assets 1.1 ----- 100.0 ===== Ten Largest Equity Investments (in alphabetical order) Company Adecco Switzerland Bayer Germany Continental Germany Deutsche Post Germany ING Netherland Novo Nordisk Denmark Publicis France Roche Switzerland Société Générale France Unicredit Italy Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: During the month the Company's NAV lost 2.1% and the share price lost 2.2%. For reference, the FTSE World Europe ex UK Index gained 0.4% during the same period. The last 6 weeks have been characterised by a significant momentum reversal. The reversal appears to have been triggered by comments at the Federal Reserve in early March resulting in investors buying up stocks with exposure to emerging markets and very aggressive short covering by Hedge Funds. In the US this was initially observable in the underperformance of Tech and Bio-tech stocks, but this has broadened out during April to constitute a broad-based reversal in market leadership. Many of the best performing stocks of the last 12 months or so have given back some of their gains. This short covering and subsequent rotation was reflected in the outperformance of consumer staples and energy, and the underperformance of financials, health care and consumer discretionary. In the meantime, Europe continued to recover during April, with the Purchasing Managers Index still in positive territory and with the European Central Bank showing stronger support than ever before for creative measures being taken if necessary, with the Governing Council stating that it is "unanimous in its commitment to also using unconventional instruments within its mandate to cope effectively with risks of a too prolonged period of low inflation". Stock selection was the main driver of the underperformance while sector allocation also detracted. From a sector perspective, the Company's underweight position to oil & gas (zero exposure) was a significant detractor from returns as it was the best performing sector over the month. An overweight position in consumer services also detracted from performance, however an underweight position in utilities proved profitable. The reversal in momentum, which saw stocks that had performed well over the last 12 months underperform in April and stocks that had underperformed over the last 12 months outperform in April, was easily visible in the Company. This could be seen in the fact that the majority of the 20 largest detractors were stocks that the Company had held and had performed well over the first quarter of 2014. This was most noticeable in the consumer services and consumer goods sectors. Within the consumer services sector, positions in Ryanair, Publicis and Reed Elsivier hindered performance. While in the consumer goods sector a position in Osram detracted from performance. The fundamentals of these businesses have not changed over the month but they have suffered as high momentum exposed stocks have been sold off. For example, since Osram was spun out of Siemens in July last year the share price had doubled up to March this year but gave 20% of that back in April due to being a mid-cap momentum stock. Similarly a position in Irish low cost airline Ryanair suffered as it has been one of the best performing stocks over the last 24 months and is again a strong recipient of an improving European economy. Positions in Russian stocks Sberbank and Gazprom have continued to detract from performance as the political crises with the Ukraine has intensified. On the positive side, positions in Turkish banks Garanti Bankasi and Halk Bankasi performed strongly as investors moved back into under owned emerging market exposed stocks. At the end of the month, the Company was positioned with higher weightings in industrials, consumer services, financials and health care and with lower weightings in consumer goods, oil & gas, basic materials, telecoms, utilities and technology. Outlook Global economic growth is expected to be positive for 2014 but the magnitude is less certain given the Chinese slowdown and US tapering. European data is increasingly pointing to a recovery and is particularly encouraging for the periphery. European political and public policy uncertainty is declining and the peak of austerity is behind us. Consensus earnings estimates have moderated since the beginning of 2014 with international earnings continuing to come under pressure from FX headwinds, while European domestic earnings are now more realistic and have scope to benefit from a domestic recovery. We maintain our projection of 8% earnings growth this year in Europe. Monetary policy remains key to global growth and the ECB may need to apply new measures to stave off disinflation risks in the Eurozone. We are spending significant time analysing the factors that can help us piece together the road map over the next 2 years. The ability of individual companies to deliver above their expected earnings will also be key over this period. 14 May 2014 ENDS Latest information is available by typing www.brgeplc.co.ukon the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings